Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-1,564
Closed -$428K 400
2018
Q1
$428K Buy
1,564
+286
+22% +$88.8K 0.04% 212
2017
Q4
$407K Buy
1,278
+1,197
+1,478% +$384K 0.05% 236
2017
Q3
$25K Sell
81
-432
-84% -$128K ﹤0.01% 268
2017
Q2
$139K Buy
+513
New +$136K 0.02% 219
2017
Q1
Sell
-8
Closed -$2K 223
2016
Q4
$2K Sell
8
-596
-99% -$177K ﹤0.01% 151
2016
Q3
$189K Sell
604
-665
-52% -$197K 0.02% 145
2016
Q2
$307K Buy
+1,269
New +$334K 0.01% 528
2015
Q4
Sell
-2,551
Closed -$733K 747
2015
Q3
$744K Buy
2,551
+133
+6% +$43.9K 0.01% 203
2015
Q2
$977K Sell
2,418
-63
-3% -$25.3K 0.02% 296
2015
Q1
$1.05M Buy
+2,481
New +$978K 0.03% 255
2014
Q4
Sell
-404
Closed -$131K 975
2014
Q3
$134K Buy
+404
New +$133K ﹤0.01% 714

Other funds holding BIIB

Jump Trading's BIIB Position: Q2 2018 in Review

Jump Trading sold out of Biogen (BIIB) in Q2 2018, closing a stake of 1,564 shares — an estimated $428K sold.

Jump Trading first reported a position in BIIB in Q3 2014 and held it in 11 quarters. The position peaked at $1.05M in Q1 2015. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Jump Trading reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • Jump Trading sold 1,564 Biogen shares in Q2 2018, an estimated $428K.
  • Jump Trading first reported a position in Biogen in Q3 2014 and held it in 11 quarters.
  • Jump Trading's Biogen position peaked at $1.05M in Q1 2015.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Jump Trading's 13F filing for Q2 2018, filed 14 Aug 2018.